CSI Market
Sign In | Register

Biohemp International (BKIT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BKIT Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Biohemp International.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(May 31 2019)
(Feb 28 2019) (Nov 30 2018) (Aug 31 2018) (May 31 2018)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Total Current Assets0.00
Total Assets0.00
Liabilities
Accounts Payable, Current AC0.04
Accrued Liabilities, Current AC0.04
Notes Payable, Current NO0.11
Other Liabilities, Current0.04
Total Current Liabilities0.24
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities0.24
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock0.25
Retained Earnings / Accumulated Deficit-0.49
Other Equity0.00
Common Stockholder's Equity-0.24
Total Stockholder's Equity-0.24
Liabilities & Stockholder's Equity0.00
4 historic quarters locked

Sign in to unlock the full Biohemp International balance sheet history.

Sign In Create Free Account

About BKIT Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.